Bacteremia due to Bacteroidacceae: a review of 92 cases.
The clinical courses of 92 patients who had bacteremia due to Bacteroidaceae were reviewed. The overall mortality rate was 21% (19 patients). There was no significant difference between mortality rates when patients were grouped by anticipated clinical course of underlying disease (nonfatal, ultimately fatal, and rapidly fatal) and when they were grouped by type of antibacterial therapy (appropriate, including clindamycin, chloramphenicol, lincomycin, and carbenicillin; or inappropriate, signifying no antibiotic treatment or treatment with antibiotics other than the four listed above). However, there was a correlation between recovery of the patient and portal of entry of the infectious agent; patients whose source of infection was the gastrointestinal tract had a mortality rate of 29% (17 of 58 patients), whereas there were no deaths among the 26 women whose presumed source of bacteremia was the genital tract. Increasing age appeared to be an important factor as well; 17 of 19 deaths occurred in patients who were older than 40 years. There was no significant difference between the mortality rate of patients who were treated with clindamycin (15%, eight of 52 patients) and that of patients who were treated with chloramphenicol (44%, four of nine).
D000328:Adult; D001438:Bacteroidaceae / Q000302:isolation & purification; D001769:Blood / Q000382:microbiology; D002701:Chloramphenicol / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality
D002981:Clindamycin; D002701:Chloramphenicol; D008034:Lincomycin